From a public health perspective, thorough gynecological and obstetrical care of incarcerated women provide an important context for detecting and treating HIV infection, and for reducing the likelihood of HIV transmission and acquisition. Additionally, they provide a critical occasion for assessing and enhancing the health of a population commonly estranged from primary care outside of corrections. The purpose of this article is to review selected sexually transmitted infections (STIs) and gynecological infections that appear to be associated with HIV infection and/or to facilitate HIV transmission; to summarize research on the Mary Jo Fink, MD, is with the Division of HIV Medicine at Albany Medical Center in Albany, New York. transmission of HIV during and after pregnancy; to summarize clinical approaches to treating HIV-infected pregnant women; and lastly, to describe a correctional sexual health class that instructs HIV-infected women about self-care and encourages at-risk women to reduce the likelihood of HIV acquisition.
Get full access to this article
View all access options for this article.
References
1.
ACOG Educational Bulletin. (January 1997). HIV infections in pregnancy, 232-232.
2.
Bureau of Justice Statistics. (May 1997). Correctional populations in the United States, 1995. United States Department of Justice, Washington, DC. (NCJ-163916)
3.
CappielloG., Garbuglia, A. R., SalviR., RezzaG., GiulianiM., PezzottiP., SuligoiB., BrancaM., MiglioreG., Formigoni PomponiD., D’UbaldoC., IppolitoG., GiacominiG., & BenedettoA. (1997). HIV infection increases the risk of squamous cell intra-epithelial lesions in women with HPV infection: An analysis of HPV genotypes. International Journal of Cancer, 72(6), 982-986.
4.
Chiasson, M. A., Ellerbrock, T. V., Bush, T. J., Sun, X. W., & Wright, T. C. Jr. (1997). Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstetrics and Gynecology, 89(5), 690-694.
5.
Connor, E. M., Sperling, R. S., GelberR., KiselevP., ScottG., O’Sullivan, M. J., VanDykeR., BeyM., ShearerW., & Jacobson, R. L. (1994). Reduction of maternal-infant transmission of HIV Type 1 with zidovudine treatment. New England Journal of Medicine, 331, 1173-1180.
6.
Covino, J. M. & McCormack, W. M. (1990). Vulvar ulcer of unknown etiology in a human immunodeficiency virus-infected woman: Response to treatment with zidovudine. American Journal of Obstetrics and Gynecology, 163, 116-118.
7.
Cu-UvinS., Flanigan, T. P., Rich, J. D., Mileno, M. D., Mayer, K. H., & Carpenter, C. C. (1996). Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women. American Journal of Medicine, 101, 316-322.
8.
Drapkin, A. L., Livingston, E. G., DodgeR.Coogan, A. C., & Herbert, W. N. (1997). Cervical intraepithelial neoplasia in HIV-infected women in a southeastern United States population. Southern Medical Journal, 90(9), 893-896.
9.
Fennema, J. S., van-Amejiden, E. J., Coutinho, R. A., & van-den-Hoek, A. A. (1995). HIV, sexually transmitted diseases and gyneacologic disorders in women: Increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS, 9(9), 1071-1078.
10.
Fink, M. J., Fruchter, R. G., MaimanM., KellyP., SedlisA., Webber, C. A., & ChenP. (1994). The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecologic Oncology, 55, 133-137.
11.
Gentile, G’, FormelliG., CostigliolaR.P., BusacchiP., & PelusiG. (1993). Cervical intraepithelial neoplasia in HIV seropositive patients. European Journal of Gynecological Oncology, 14(3), 246-248.
12.
GoodmanA., GarrettA., & ChaudhuriA. (1996). Vulvar and cervical neoplasia in high-risk HIV seropositive and seronegative women. New England Association of Gynecologic Oncologists. (NEAGO abstract, page 10)
13.
GullotaG., MargaritiP.A., RabittiC., BalsamoG., ValleD., CapelliA., & MancusoS. (1997). Cytology, histology, and colposcopy in the diagnosis of neoplastic non-invasive epithelial lesions of the cervix. European Journal of Gynaecologic Oncology, 18(1), 36-38.
14.
Higgins, G. D., Phillips, G. E., Smith, L. A., Uzelin, D. M., & Burrell, C. J. (1992). High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer, 70, 136-146.
15.
HoegsbergB., AbulafiaO., SedlisA., FeldmanJ., DesJalaisD., LandesmanS., & MinkoffH. (1990). Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. American Journal of Obstetrics and Gynecology, 163(4), 1135-1139.
16.
IrwinK., RiceR., SperlingR., O’SullivanM.J., & BrodmanM. (1994). Potential for bias in studies of the influence of human immunodeficiency virus infection on the recognition, incidence, clinical course and microbiology of pelvic inflammatory disease. Obstetrics & Gynecology, 84(3), 463-469.
17.
Klevens, R. M., Fleming, P. L., MaysM., & FreyR. (1996). Characteristics of women with AIDS and invasive cervical cancer. Obstetrics and Gynecology, 88(2), 269-273.
18.
Korn, A. P., LandersD., GreenJ., & SweetR. (1993). Pelvic inflammatory disease in human immunodeficiency virus-infected women. Obstetrics & Gynecology, 82(5), 765-768.
19.
LagaM., ManokaA., KivuvuM., MaleleB., Tuliza M., NzilaN., GoemanJ., BehetsF., BatterV., & AlaryM. (1993). Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women. AIDS, 7(1), 95-102.
20.
MaimanM., Fruchter, R. G., SerurE., Remy, J. C., FeuerG., & BoyceJ. (1990). Human immunodeficiency virus infection and cervical neoplasia. Gynecologic Oncology, 38(3), 377-382.
21.
MaimanM., Fruchter, R. G., ClarkM., Arrastia, C. D., MatthewsR., & Gates, E. J. (1997). Cervical cancer as an AIDS-defining illness. Obstetrics and Gynecology, 89(1), 76-80.
22.
MaimanM., TarriconeN., VieiraJ., SuarezJ., SerurE., & BoyceJ. (1991). Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstetrics and Gynecology, 78(1), 84-88.
23.
MayerK., & Anderson, D. J. (1995). Heterosexual HIV transmission. Infectious Agents and Disease, 4(4), 273-284.
24.
MinkoffH., Burns, D. N., LandesmanS., YouchahJ., Goedert, J. J., Nugent, R. P., Muenz, L. R., & Willoughby, A. D. (1996). The relationship of the duration of ruptured membranes to vertical transmission of HIV. American Journal of Obstetrics and Gynecology, 173(2), 585-589.
25.
MostashariF., RileyE., Selwyn, P. A., & Altice, F. L. (in press). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndrome.
26.
Mumola, C. J., & Beck, A. J. (1997, June). Prisoners in 1996. Bureau of Justice Statistics Bulletin, Washington, DC. (NCJ-164619)
27.
National Institute of Allergy & Infectious Disease (1996). Bethesda, MD.
28.
Padian, N. S., Shiboski, S. C., Glass, S. O., & VittinghoffE. (1997). Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study. American Journal of Epidemiology, 146(4), 350-357.
29.
Plummer, F. A., Simonsen, J. N., Cameron, D. W., Ndinya-Achola J. O., Kreiss, J. K., Gakinya, M. N., WaiyakiP., CheangM., PiotP., & Ronald, A. R. (1991). Co-factors in male-female transmission of HIV. Journal of Infectious Disease, 163, 233-239.
30.
QuinnT. (1996). Association of sexually transmitted diseases and infection with human immunodeficiency virus: Biological co-factors and markers of behavioral interventions. International Journal of Sexually Transmitted Disease and AIDS, 7(2), 17-24.
31.
ReadJ. (1998, July). Mode of delivery and vertical transmission of HIV-1: A meta-analysis from fifteen prospective cohort studies. International AIDS Conference, Geneva, Switzerland. (Abstract 23275)
32.
Robinson, W. R., Barnes, S. E., AdamsS., & Perrin, M. S. (1997). Histology/cytology discrepancies in HIV-infected obstetric patients with normal Pap smears. Gynecologic Oncology, 65(3), 430-433.
33.
RojanskyN., & AntebyS.O. (1996). Gynecological neoplasia in the patient with HIV infection. Obstetrical and Gynecological Survey, 51(11), 679-683.
34.
SewankamboN., Gray, R. H., Wawer, M. J., PaxtonL., McNaimD., Wabwire-MangenF., SerwaddaD., LiC., KiwanukaN., Hillier, S. L., RabeL., Gaydos, C. A., Quinn, T. C., & Konde-LuleJ. (1997). HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet, 350(9077), 546-550.
35.
SillmanF., StanekA., SedisA., RosenthalJ., Lanks, K W., BuchhagenD., NicastriA., & BoyceJ. (1984). The relationship between human papillomavirus and lower genital tract intraepithelial neoplasia in inmunosuppressed women. American Journal of Obstetrics & Gynecology, 150(3), 300-308.
36.
Simpson, B. J., Shapiro, E. D., & Andiman, W. A. (1997). Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. Journal of Acquired Immune Deficiency Syndrome, 14(2), 145-152.
37.
Snell, T. L., & Morton, D. C. (1994, March). Women in prison. Bureau of Justice Statistics Special Report, Washington, DC.
38.
StevensJ., ZierlerS., CramV., DeanD.MayerK., & De Groot, A. S. (1995). Risks for HIV infection in incarcerated women. Journal of Women’s Health, 4(5), 569-577.
39.
Sun, X. W., KuhnL., EllerbrockT.V., Chiasson, M. A., Bush, T. J., & Wright, T. C. (1997). Human papillomavirus infection in women infected with the human inimunodeficiency virus. New England Journal of Medicine, 337(19), 1343-1349.
40.
United States Public Health Service Task Force. (1994). Recommendations on the use of zidovudine to reduce perinatal transmission of HIV. Morbidity and Mortality Weekly Review, 43-43.
41.
United States Public Health Service Task Force. (1995). Recommendations for HIV Counseling and Voluntary Testing for Pregnant Women. Morbidity and Mortality Weekly Review, 44-44.
42.
United States Public Health Service Task Force. (1998). Recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Morbidity and Mortality Weekly Review, 47-47.
43.
WortleyP., & FlemingP. (1997). AIDS in women in the United States: Recent trends. Journal of the American Medical Association, 247, 911-916.
44.
Wright, T. C. Jr., Moscarelli, R. D., DoleP., EllerbrockT.V., Chiasson, M. A., & VandevanterN. (1996). Significance of mild cytologic atypia in women infected with human inmunodeficiency virus. Obstetrics and Gynecology, 87(4), 515-519.
